Efficacy of Mirdametinib Alone or Combination With Radiotherapy for Germline and Sporadic NF1-Altered High-Grade Glioma

NCT07521657 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

55

Enrollment

OTHER

Sponsor class

Conditions

Neurofibromatosis 1 (NF1)

Interventions

COMBINATION_PRODUCT: mirdametinib with radiation
DRUG: mirdametinib

Sponsor

University of Alabama at Birmingham

Collaborators

[object Object]
[object Object]